A new startup called Whiterabbit has emerged from stealth to announce its new CEO and the FDA clearance of its artificial intelligence-enabled breast cancer screening product.
The company has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection, with the goal of eradicating late-stage breast cancers in the U.S. by 2025.
The WRDensity...
YourCoach.Health, a practice management platform for health and wellness coaches, is taking its services corporate by launching an employee-centric version of its platform.
The company is now partnering with employer organizations to provide health and wellness coaching to workers.
Using its patent-pending algorithms and a YourCoach concierge, the company pairs each employee with a health coach...
This morning, Bigfoot Biomedical announced it has received FDA 510(k) clearance for its Bigfoot Unity Diabetes Management System.
The system was cleared for use among individuals 12 years old and up with Type 1 or Type 2 diabetes who use multiple-dose injection therapy.
Included in the Bigfoot Unity System are two smartpen caps for both rapid- and long-acting insulin, a connected mobile app, an...
Genesis MedTech, a medical device company, is working to get its articulating laparoscopic devices to China and Singapore.
It recently signed a strategic distribution deal with Korean medical device firm LivsMed to market its ArtiSential instruments, which were first brought to South Korea in 2018.
WHAT IT'S FOR
The ArtiSential series of articulating laparoscopic instruments provide users with...
Walmart this week strengthened its foothold as a healthcare provider with the announcement of its plans to acquire telehealth company MeMD.
The retail giant’s healthcare arm, Walmart Health, will bring MeMD’s multi-specialty virtual care options into its fold later this year.
The deal is expected to close in the coming months, following regulatory approvals, according to the announcement. The...
Viome, maker of at-home test kits for gut, immune and cellular health, has received FDA breakthrough device designation for its mRNA analysis technology and artificial intelligence platform that detect early signs of oral cancer and throat cancer.
The FDA designation validates the technology used in Viome’s at-home Health Intelligence Test that analyzes users’ microbial, human and mitochondrial...
CARESYNTAX SECURES €83M FOR AI HOSPITAL
Berlin-based healthtech company Caresyntax has raised €82.8 million ($100 m) in a Series C round. The investment was led by PFM Health Sciences LP, Optum Ventures, Intel Capital and Lauxera Capital Partners and is one of the largest rounds secured by a German healthtech company.
The company uses AI to digitise operation rooms by developing algorithms that...
Today a patient's ZIP code can say a lot about their life expectancy and health outcomes. In the U.S. especially, healthcare costs are high, leaving some without access to care. This has left innovators to look to digital as a way to help in scaling care and lowering costs. Big tech especially is jumping into the healthcare game.
During a panel at the Vatican Conference on health this morning, Dr...
Pharma giant Eli Lilly has inked a series of deals with four diabetes management companies to integrate with its forthcoming Tempo Pen and Tempo Smart Button products.
The companies that signed strategic international agreements with Eli Lilly are Dexcom, Glooko, myDiabby Healthcare and Roche.
Through the agreements, Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the...
Germany is set to enter an era of digital health over next few years, making it a significant market for health tech solutions.
Digital health analysis and consultancy firm Research2Guidance (R2G) has published a white paper examining the challenges and opportunities, in light of Germany’s new digital health application (DiGA) fast track approval process.
Legislative changes under the 2019...
